Chief Financial Officer
Timothy Cruickshank commenced with ImpediMed in January 2008, was promoted to Vice President of Finance in July 2016, to Executive Vice President of Finance and Acting CFO in March 2020, and to Chief Financial Officer in August 2020. Tim has more than 10 years of experience in financial management in the medical technology industry. He has a strong background in operations, finance and accounting, and a proven track record of strong financial management, SaaS modeling and strategy for start-ups and emerging growth companies, both private and public. Tim holds a Master of Financial and Accounting Management from Keller Graduate School of Management in Queens, New York and a Bachelor of Science, Accounting from the Syracuse University in Syracuse, New York.